Clinical Trials Directory

Trials / Completed

CompletedNCT05127707

Strategies to Reduce Addiction Stigma Among Health Professionals

Effect of Exposure to Visual Campaigns and Narrative Vignettes on Addiction Stigma Among Health Professionals: A Randomized Experiment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,842 (actual)
Sponsor
Johns Hopkins Bloomberg School of Public Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this study was to evaluate the effects of exposure to stigma reduction message frames communicated by visual campaigns and narrative vignettes among a national sample of health professionals.

Detailed description

This randomized experiment evaluated the impact of exposure to message frames communicating the importance of non-stigmatizing language regarding addiction and the effectiveness of medication treatment for opioid use disorder delivered through a visual campaign alone or through a visual campaign in addition to a narrative vignette from the perspective of one of three messengers (a person with opioid use disorder, a clinician, or a health system leader) on attitudes toward people with opioid use disorder and medications for treating opioid use disorder among a national sample of health professionals.

Conditions

Interventions

TypeNameDescription
BEHAVIORALWords Matter - Visual CampaignVisual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings.
BEHAVIORALWords Matter - Visual Campaign & Narrative Vignette (Messenger: Person with Opioid Use Disorder) Experimental: Words Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician)Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings combined with a narrative vignette told from the perspective of a person with opioid use disorder
BEHAVIORALWords Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician)Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings combined with a narrative vignette told from the perspective of a clinician working with patients with opioid use disorder
BEHAVIORALWords Matter - Visual Campaign & Narrative Vignette (Messenger: Health System Administrator)Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings combined with a narrative vignette told from the perspective of a health system administrator/leader
BEHAVIORALMedication Treatment for Opioid Use Disorder Works - Visual CampaignVisual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives
BEHAVIORALMedication Treatment for Opioid Use Disorder Works - Visual Campaign & Narrative Vignette (Messenger: Person with Opioid Use Disorder)Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives combined with a narrative vignette told from the perspective of a person with opioid use disorder
BEHAVIORALMedication Treatment for Opioid Use Disorder Works - Visual Campaign & Narrative Vignette (Messenger: Clinician)Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives combined with a narrative vignette told from the perspective of a clinician who treats people with opioid use disorder
BEHAVIORALMedication Treatment for Opioid Use Disorder Works - Visual Campaign & Narrative Vignette (Messenger: Health System Administrator)Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives combined with a narrative vignette told from the perspective of a health system administrator/leader

Timeline

Start date
2020-11-13
Primary completion
2020-11-30
Completion
2020-11-30
First posted
2021-11-19
Last updated
2021-11-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05127707. Inclusion in this directory is not an endorsement.